← Back to Search

Colorectal Cancer Screening Program for Colorectal Cancer

N/A
Recruiting
Led By Roshan Bastani
Research Sponsored by Jonsson Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
PATIENTS: 50-75 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial aims to increase CRC screening rates in minority & low-income groups with a tailored program & FIT test to detect signs of CRC sooner.

Who is the study for?
This trial is for low-income and ethnic minority individuals aged 50-75 who have visited a clinic at least once in the past two years. It aims to increase colorectal cancer screening rates within these groups.Check my eligibility
What is being tested?
The study tests a culturally-tailored program that includes educational interventions, text message reminders, feedback, and fecal immunochemical testing (FIT) to improve colorectal cancer screening among eligible patients.See study design
What are the potential side effects?
Since this trial focuses on education and screening rather than medication or invasive procedures, there are no direct side effects from the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal cancer (CRC) screening rate
Rate of failure to provide a FIT kit to an eligible patient making a clinic visit
Return rate of completed FIT kits

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (education, feedback, consult, FIT kit, text message)Experimental Treatment8 Interventions
Physicians and clinic staff receive ongoing training, education, and feedback on CRC screening, and utilize point-of-care clinical decision support tool throughout the trial. Patients receive CRC screening recommendations from provider, a FIT kit with culturally tailored instructions, consultation with clinic staff, and text message reminders throughout the trial.
Group II: Arm II (usual care)Active Control2 Interventions
Physicians and clinic staff provide and patients recieve CRC screening usual care throughout the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Feedback
2018
N/A
~18230
Health Education
2014
Completed Phase 3
~4010

Find a Location

Who is running the clinical trial?

Jonsson Comprehensive Cancer CenterLead Sponsor
361 Previous Clinical Trials
23,812 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
16,618 Total Patients Enrolled
Roshan BastaniPrincipal InvestigatorUCLA / Jonsson Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial extend to individuals of advanced age?

"According to the trial's criteria, no one under 50 nor over 75 can join this clinical study."

Answered by AI

Are researchers currently recruiting for this experiment?

"This clinical trial, which was initially launched on November 1st of 2019 and recently updated on October 13th 2023, is actively recruiting patients according to the data presented on ClinicalTrials.gov."

Answered by AI

Do I qualify to participate in this research endeavor?

"Patients aspiring to join this clinical trial should have colorectal cancer and be between 50-75 years old. This research study is aiming to recruit up to 4000 participants."

Answered by AI

How many participants are being accepted to participate in this research?

"Yes, according to the entries on clinicaltrials.gov, this research project is still recruiting patients. The trial was first announced on November 1st 2019 and has been amended for the last time in October 13th 2023. 4000 subjects are expected to be recruited from a single site."

Answered by AI
~400 spots leftby Nov 2024